• PMD51 Cost-Effectiveness of a Predictive Test of the Benefit of Chemotherapy

    Nov 1, 2012, 00:00

  • PRM112 Recruitment Costs and Efficiency Varies With Condition/ Patient Population

    Nov 1, 2012, 00:00

  • PCN22 Cost-Effectiveness Analysis of Cervical Cancer Screening With Self-Sampling for Human Papillomavirus (HPV) Testing in Taiwan

    Nov 1, 2012, 00:00

  • PHP108 Early Access Programmes (EAPs)- Review of Non- European System

    Nov 1, 2012, 00:00

  • PR3 Utility Values for Chemotherapy-Related Adverse Events- A Review of the Literature

    Nov 1, 2012, 00:00

  • PND69 Development and Validation of a Patient-Reported Outcomes Questionnaire for the Assessment of Hereditary Angioedema in Observational Studies

    Nov 1, 2012, 00:00

  • PHP47 Dose Dependent Evaluation of Intestinal P-GP Activity After One Week Oral Administration of Bacopa Monniera

    Nov 1, 2012, 00:00

  • PSS28 Long-Term Improvement in Patient-Reported Outcomes After Transition From Methotrexate to Ustekinumab in Moderate to Severe Psoriasis- Transit Week 52 Results

    Nov 1, 2012, 00:00

  • PRM12 Joint Estimation of Progression Free Survival and Overall Survival

    Nov 1, 2012, 00:00

  • PMD84 Telemonitoring After Discharge With Heart Failure - Cost-Effectiveness Modelling of Alternative Service Designs

    Nov 1, 2012, 00:00

  • PGI24 Cost-Effectiveness Analysis of 48-Week Peginterferon Alpha-2a Under RGT Strategy Versus 3 Years Entecavir for the Treatment of HBeAg-Positive Chronic Hepatitis B in China

    Nov 1, 2012, 00:00

  • PHP90 The Risk of Withdrawal from Labor Force in Patients with Bipolar Disorders in Taiwan

    Nov 1, 2012, 00:00

  • PHP204 Appropriate Methods for Economic Evaluation of Programmes with Costs and Effects Extending Across Sectors

    Nov 1, 2012, 00:00

  • PCV21 Hospital Based Cost Survey of Acute Coronary Syndrome in South Korea

    Nov 1, 2012, 00:00

  • PMH27 Cost-Effectiveness Analysis of Depression in Italy

    Nov 1, 2012, 00:00

  • PMS17 Burden of Ankylosing Spondylitis in Urban China

    Nov 1, 2012, 00:00

  • PMS12 Budget Impact of Golimumab in the Anti-TNF Treatment of Rheumatoid Arthritis, Akylosing Spondylitis and Psoriatic Arthritis in the Brazilian Public Health Care System

    Nov 1, 2012, 00:00

  • PIH1 Pregnancy Outcomes After Maternal Exposure to Topical Corticosteroids- A Population-Based Cohort Study

    Nov 1, 2012, 00:00

  • PHS93 HbA1c Test Utilization Among Hospitalized Patients With Hyperglycemia

    Nov 1, 2012, 00:00

  • PCV8 Evaluation of Efficacy and Safety of Antihypertensive Drugs on the Reimbursement List for Delisting Policy in Korea

    Nov 1, 2012, 00:00

  • PMS80 Biologic Therapies for Rheumatoid Arthritis – Eligibility Criteria in the UK

    Nov 1, 2012, 00:00

  • PCV85 Persistence of Patients Treated Hypertensive Medication in PBM With Different Percentages of Financial Subsidy

    Nov 1, 2012, 00:00

  • PRM37 Development and Use of a Health-Related Quality of Life Tool to Help Veterinarians and Pet Owners Assess Aging Changes in Pet Dogs

    Nov 1, 2012, 00:00

  • PSU9 Budget Impact of Autograft Harvest, Bone Graft Supplements and Orthobiologic Bone Graft Substitute in Foot and Ankle Fusion Procedures

    Nov 1, 2012, 00:00

  • PUK6 Comparison of Quality of Life Between Hemodialysis and Peritoneal Dialysis Patients in a Tertiary Hospital in China

    Nov 1, 2012, 00:00

  • PCV53 Economic Evaluation of a Single Pill Triple Antihypertensive Therapy With Valsartan, Amlodipine, and Hydrochlorothiazide Against Its Dual Components in Greece

    Nov 1, 2012, 00:00

  • PMH33 Cost Effectiveness of Paliperidone Palmitate Versus Oral Medication in the Treatment of Schizophrenia in Austria

    Nov 1, 2012, 00:00

  • PIH11 Cost of Unintended Pregnancy in the UK- A Role for Increased Use of Long-Acting Reversible Contraceptive Methods

    Nov 1, 2012, 00:00

  • PMD2 Hematologic Cancers- Diagnostic Testing Patterns and the Role of Specialty Laboratories in the Age of Personalized Medicine

    Nov 1, 2012, 00:00

  • CN1 Statins and the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Virus Infection

    Nov 1, 2012, 00:00

  • PHS87 Cost of Diabetes in Insulin-Treated Patients in Bulgaria

    Nov 1, 2012, 00:00

  • PHP171 HTA Principles Inclusion in New European Union Member States

    Nov 1, 2012, 00:00

  • PIN1 Efficacy and Safety of Tenofovir as Compared With Alternative Treatment Options for Naive Chronic Hepatitis B – a Systematic Review and Mixed Treatment Comparison

    Nov 1, 2012, 00:00

  • PCN102 The Cost of Absenteeism and Short-Term Disability Associated With Colorectal Cancer- A Case-Control Study

    Nov 1, 2012, 00:00

  • PMS16 Economic Evidence of Biologics in Rheumatoid Arthritis- A Systematic Review for Supporting Informed Decision of BNHI

    Nov 1, 2012, 00:00

  • PMD15 Budget Impact Analysis of Vascular Closure Devices (VCDs) in Italy and Spain

    Nov 1, 2012, 00:00

  • PRM25 First Drive-Through Pharmacy Service in Taiwan

    Nov 1, 2012, 00:00

  • PCN90 Cost Effectiveness Analysis of Bendamustine as First Line Treatment for Chronic Lymphocytic Leukaemia in the Netherlands

    Nov 1, 2012, 00:00

  • PHP48 Irrational Use of Antibiotics in Balochistan. A Warning for Health Care System

    Nov 1, 2012, 00:00

  • PRS16 Socioeconomic Burden of COPD in Ukraine- 2012-2020 Perspective Modeling

    Nov 1, 2012, 00:00

  • PND13 Old and New Antiepileptic Drugs Utilization in Iran

    Nov 1, 2012, 00:00

  • PHP52 The Cardiovascular Drug Utilisation in Croatia in the Period 2007-2010, Trends and Perspectives

    Nov 1, 2012, 00:00

  • PRM10 Use of VA Databases for Retrospective Studies in Ulcerative Colitis Outcomes Research

    Nov 1, 2012, 00:00

  • PCN61 Melody Brazil – Resource Use and Associated Costs With Metastatic Melanoma in Brazilian Health Care System

    Nov 1, 2012, 00:00

  • PRM151 Collapsibility and Censoring- What's the Bias in Estimated Survival Time?

    Nov 1, 2012, 00:00

  • PMD4 Cardiovascular Risk Prevalence in High Risk Primary Care Patients Not Treated With Lipid-Lowering Treatment in France, Results of an Online Study

    Nov 1, 2012, 00:00

  • PHP3 Integration of Evidence on Patient Preferences in Health Care Decision Making- Current State of Play

    Nov 1, 2012, 00:00

  • PRM135 Validity, Reliability and Responsiveness of the Spanish Minnesota Living With Heart Failure Questionnaire

    Nov 1, 2012, 00:00

  • PRS15 The Economic Impact of COPD in Patients of Working Age- Results From ‘COPD Uncovered' the Netherlands

    Nov 1, 2012, 00:00

  • VA1 A European-Wide Study on the Role of Streptococcus Pneumoniae in Community-Acquired Pneumonia among Adults- A Meta-Analysis

    Nov 1, 2012, 00:00

  • PRM137 Reminders Help Improving Completion Rate of Home-Administered Lifestyle Questionnaires

    Nov 1, 2012, 00:00

  • PCN33 Health Related Quality of Life in Post-Operative Breast Cancer Patients

    Nov 1, 2012, 00:00

  • PHP120 New Pricing Dynamics in Big Five EU- Case Study of Biosimilar GM-CSF Products

    Nov 1, 2012, 00:00

  • PHS16 Relationship of Polymedication in Controlling Blood Pressure- Compliance, Persistence, Costs and Incidence of New Cardiovascular Events

    Nov 1, 2012, 00:00

  • PSY41 Symptoms and Impacts Associated With Anaemia of Chronic Kidney Disease (CKD)

    Nov 1, 2012, 00:00

  • PIN8 Assessment of Tuberculosis Burden in China Using a Dynamic Disease Simulation Model

    Nov 1, 2012, 00:00

  • PIN3 Burden of Cytomegalovirus Disease in Immunosuppressed Persons Following Transplantation in France

    Nov 1, 2012, 00:00

  • DB2 Economic Consequences of Severe Hypoglycaemia – Preliminary Findings from Five Central European Countries

    Nov 1, 2012, 00:00

  • PRM42 Managing a Systematic Literature Review Project

    Nov 1, 2012, 00:00

  • PHP47 Impact of Economic and Policy Factors on China'S Health Care Expenditure

    Nov 1, 2012, 00:00

  • PIH9 Compare Health Care Utilization and Costs among Menopausal Women with Different Symptoms by Linking Women's Registry and Claims Database

    Nov 1, 2012, 00:00

  • DU2 Contribution of Prolonged-Release Melatonin and Anti-Benzodiazepine Campaigns to the Reduction of Benzodiazepine and Z-Drug Consumption in Nine European Countries

    Nov 1, 2012, 00:00

  • PMH13 Dementia and Alzheimer'S Disease in China- Characterization and Caregiver Burden

    Nov 1, 2012, 00:00

  • PRM73 The Use of Cumulative Hazard Plots to Inform Resource Allocation and Research Decisions in Health Care

    Nov 1, 2012, 00:00

  • PMD63 A Review of Economic Evaluation Models for Cardiac Resynchronization Therapy With Implantable Cardioverter Defibrillators in Patients With Heart Failure

    Nov 1, 2012, 00:00

  • PGI31 Impact of Treatment Response on Health Utilities and Work Productivity Among Patients With Irritable Bowel Syndrome With Constipation- Pooled Results From Phase III Clinical Trials

    Nov 1, 2012, 00:00

  • PRM35 Relative Efficiency of the SF-8, SF-12, and SF-36 in the General Population

    Nov 1, 2012, 00:00

  • PUK23 Burden of Chronic Kidney Disease in German Diabetes Patients, a Systematic Literature Review and Data Gap Analysis

    Nov 1, 2012, 00:00

  • PCN111 The Value of Personalizing Medicine- Medical Oncologists' and Patients' Perspectives on Genomic Testing of Breast Tumours in Chemotherapy Treatment Decisions

    Nov 1, 2012, 00:00

  • PGI21 Cost Effectiveness of the Combination of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Telaprevir Plus Peginterferon Alfa and Ribavirin in the Retreatment of Patients With Chronic Hepatitis C Virus Genotype I Infection

    Nov 1, 2012, 00:00

  • PRM80 Proportional Hazards Assumption and Its Impact on Results of Cost-Effectiveness Analysis

    Nov 1, 2012, 00:00

  • PHP2 Economic Cost Savings of Technological Improvement for Lower-Level Hospitals- A Pilot Study in China

    Nov 1, 2012, 00:00

  • PHS40 An Example of Irrational Decision Making in the Elderly- Why are Pharmacological Therapies Preferentially Reimbursed Over Non-Pharmacological Therapies for Insomnia?

    Nov 1, 2012, 00:00

  • PHS65 Mapping the Disease-Specific FACT-P to the Preference-Based EQ-5D in Castration-Resistant Prostate Cancer

    Nov 1, 2012, 00:00

  • PMD39 The Economic Burden of Atrial Fibrillation among Elderly Populations in Selected Developed Countries

    Nov 1, 2012, 00:00

  • PHP7 Health Care Decision Making in Mainland China, Korea, and Taiwan- The Road Ahead?

    Nov 1, 2012, 00:00

  • PHP115 Geographical Distribution of Pharmacies Versus Population- The Case of Two Capital Cities in Iran

    Nov 1, 2012, 00:00

  • PCV3 One-Year Outcomes and Prognostic Factors in Severe Sepsis and Septic Shock Survivors

    Nov 1, 2012, 00:00

  • PCV48 Systematic Review of Cost-Effectiveness Models for Pharmacologic Stroke Prevention in Atrial Fibrillation

    Nov 1, 2012, 00:00

  • PHS46 Cost-Effectiveness of a Secondary Prevention Program in Patients With Myocardial Infarction- Results from a Randomised Controlled Trial (Proactive Heart)

    Nov 1, 2012, 00:00

  • PCN46 Cost-Efficacy Analysis of Licensed Drugs for the Treatment of Metastatic Castrate Resistant Prostate Cancer Post Docetaxel Based on Hospital Drug Evaluation Methodology in Spain

    Nov 1, 2012, 00:00

  • PHS11 Relationship Between Physical Function and Muscle Strength in the United States Elderly Population

    Nov 1, 2012, 00:00

  • PRM115 Modelling the Relationship Between Disease Severity and Utility in Multiple Sclerosis

    Nov 1, 2012, 00:00

  • QL4 The Impact of Disease Information on General Public Preferences for Health States- Comparing Labeling, Disease-Specific, and Adaptation Information

    Nov 1, 2012, 00:00

  • PMD75 Does Presenting Follow-Up Test Information Affect People's Preferences for Colorectal Cancer Screening Tests? A Discrete Choice Experiment

    Nov 1, 2012, 00:00

  • PHP79 Review of Research Guidelines for Economic Evaluation Proposed by the Government and Government-Funded Research Groups in Japan

    Nov 1, 2012, 00:00

  • PRM2 Assessing Relative Clinical Value Within Three Metastatic Diseases

    Nov 1, 2012, 00:00

  • PMD9 A Comparative Assessment of Cost Implications of Novel Drug Versus Novel Device-Based Treatments for Stroke Prevention in Atrial Fibrillation

    Nov 1, 2012, 00:00

  • PCV102 Characteristics Influencing Japanese Atrial Fibrillation Patients Preferences for Anticoagulants Use

    Nov 1, 2012, 00:00

  • PHP127 Reimbursement of Orphan Drugs- What is the Difference?

    Nov 1, 2012, 00:00

  • PIH37 Trends of Quality of Life in South Korean Adults During 2007-2010

    Nov 1, 2012, 00:00

  • PMS18 Impact of Etanercept-Methotrexate Therapy on Patient-Reported Outcomes in Moderately Active Rheumatoid Arthritis (RA) Patients of Europe, Latin America, and Asia

    Nov 1, 2012, 00:00

  • PND16 Qualitative Research Describing Patients' Perspectives of Successful Prophylactic Treatment With Botulinum Toxin Type a for Chronic Migraine

    Nov 1, 2012, 00:00

  • PDB31 The Prevalence and Burden of Comorbid Hypertension and Obesity Among Patients With Type 2 Diabetes in Urban China

    Nov 1, 2012, 00:00

  • PRM119 Mapping Between Composite Measures in Psoriatic Arthritis and the SF-6D- Analysis From the Grace Dataset

    Nov 1, 2012, 00:00

  • PUK15 Sevelamer in Early Stages Nondialysis-Dependent Chronic Kidney Disease (NDD-CKD) Dominates Calcium Carbonate Through Reduction of Deaths and Hospitalizations

    Nov 1, 2012, 00:00

  • PDB18 Direct Medical Costs of Diabetes Mellitus in China- Annual Cost of Illness and Long-Term Projections Using a Validated Diabetes Model

    Nov 1, 2012, 00:00

  • PCV16 Use of ACE Inhibitors in Serbia in 2009 and 2010

    Nov 1, 2012, 00:00

  • PND4 Capsaicin 8% Patch Monotherapy for Treatment of Post-Herpetic Neuralgia- Integrated Analysis of Phase III Studies

    Nov 1, 2012, 00:00

  • MO2 Impact of Structural Assumptions on Cost-Effectiveness Outcomes- Towards a Standardized Cost-Effectiveness Model for Adjuvant Breast Cancer Therapies

    Nov 1, 2012, 00:00

  • PMS20 Total Health Care Costs Associated With Rheumatoid Arthritis Incident Cases in Turkey

    Nov 1, 2012, 00:00

  • PHS13 Costs Analysis of a Mobile Phone Telemonitoring System for Glycaemic Control in Patients With Diabetes Mellitus (DM) in Spain- Preliminary Results

    Nov 1, 2012, 00:00

  • PHS75 Analysis of Costs and Reimbursement of Hospital Treatment of Venous Thromboembolism in Poland

    Nov 1, 2012, 00:00

  • PRM91 How Do Patients With Different Conditions Describe Their Pain?

    Nov 1, 2012, 00:00

  • PCN157 Conceptual Framework for the Evaluation of Patient Access Schemes (PAS) in the EU

    Nov 1, 2012, 00:00

  • PMH19 A Rehabilitation Intervention to Help People With Severe Mental Illness Obtain and Keep a Paid Job- The Economic Evaluation

    Nov 1, 2012, 00:00

  • PHS38 Cost-Effectiveness Analysis of a Helpline for Suicide Prevention

    Nov 1, 2012, 00:00

  • PHP187 Pharmacovigilance and the Case Study of VIOXX

    Nov 1, 2012, 00:00

  • PDB22 The Direct Medical Cost for Diabetes Mellitus (DM) Related Complications in China

    Nov 1, 2012, 00:00

  • PDB26 Evidence Requirements in Australia for Drug Reimbursement- The Survival of Cost Minimisation Analysis

    Nov 1, 2012, 00:00

  • RU3 Some Issues With the Icer in Technology Assessments of Screening Interventions for Rare Conditions

    Nov 1, 2012, 00:00

  • PDB60 Preliminary Results on the Reliability and Validity of the Worry Subscale of the Hypoglycaemic Fear Survey-II for Assessing the Impact of Fear for Hypoglycemia on the Health-Related Quality of Life of Type 2 Diabetes Mellitus Patients ...

    Nov 1, 2012, 00:00

  • PIH10 Utility Values for Use in Health Care Decision Making for Older Frail Adults

    Nov 1, 2012, 00:00

  • PHP68 The Effect of Resetting the Clock in Health Care

    Nov 1, 2012, 00:00

  • PHP48 Health Financing for Prisoners with HIV- Lesson Learned from Indonesia

    Nov 1, 2012, 00:00

  • PMD61 Cost-Effectiveness of Positron Emission Tomography in Head and Neck Squamous Cell Carcinoma- A Systematic Review

    Nov 1, 2012, 00:00

  • PND10 Economic Evaluation of Interferon âeta-1A Versus Interferon âeta-1B in the Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) in Iran

    Nov 1, 2012, 00:00

  • PHP31 The Value of Investigational Medical Products

    Nov 1, 2012, 00:00

  • PHP90 Japanese Pricing Reform in April 2012- Toward Cost Containment

    Nov 1, 2012, 00:00

  • PSY38 Spontaneous and Probed Disease-Defining Concepts Identified Through Concept Elicitation Interviews in Chronic Low Back Pain

    Nov 1, 2012, 00:00

  • PIN16 Tuberculosis Treatment Outcomes in Patients With and Without Diabetes Mellitus

    Nov 1, 2012, 00:00

  • PIH2 Duloxetine Use in Pregnancy- A Prospective, Comparative Study of Exposed Infants

    Nov 1, 2012, 00:00

  • PCV23 Economic Evaluation of Ezetimibe Co-Administration for High Coronary Heart Disease (CHD) Risk Patients Not at Goal With Current Statin Therapy in Thailand

    Nov 1, 2012, 00:00

  • MA1 Utilization of Disease Modifying Agents in Multiple Sclerosis- Analysis From an Italian Administrative Database

    Nov 1, 2012, 00:00

  • PMS15 An Economic Evaluation of Denosumab in the Treatment of Postmenopausal Osteoporosis in a Taiwanese Setting

    Nov 1, 2012, 00:00

  • PUK2 Issues in the Systematic Review of Drugs for Rare Diseases- A Case Study of Eculizumab for aHUS

    Nov 1, 2012, 00:00

  • PSY6 Economic Efficiency of Ferric Carboxymaltose to Treat or Prevent Iron Deficiency Anemia- Value to the Portuguese Hospitals

    Nov 1, 2012, 00:00

  • PMS59 Impact of Comorbidities on Measuring Indirect Utility by the Medical Outcomes Study Short Form 6D in Lower-Limb Osteoarthritis

    Nov 1, 2012, 00:00

  • PRM102 Validation of the Russian Version of Schizophrenia Quality of Life Questionnaire (S-QoL)

    Nov 1, 2012, 00:00

  • PCV100 Comparison of Health-Related Work Impairment in Russian Patients with US and 5EU

    Nov 1, 2012, 00:00

  • PCV4 The Optimal Interval of Framingham Risk Score to Detect Cardiovasular Disease in Healthy Adults- A Large Cohort Study in Japan

    Nov 1, 2012, 00:00

  • PND56 Assessing the Quality of Life in a Spanish Population With Multiple Sclerosis- The Slims Study

    Nov 1, 2012, 00:00

  • PCN16 Comparison of the Efficacy and Cost of Novel Targeted Cancer Therapies

    Nov 1, 2012, 00:00

  • PHP81 Factors Influencing Interprofessional Collaboration- A Literature Review from 2004-2011

    Nov 1, 2012, 00:00

  • PGI28 Gastroesophageal Reflux Disease- Impact on Work Productivity and Daily Life Activities of Daytime Workers. A French Cross Sectional Study (ACTA)

    Nov 1, 2012, 00:00

  • PIN2 Estimating the Additive Effects of Length of Stay on Contracting Clostridium Difficile Infection

    Nov 1, 2012, 00:00

  • PHP60 Assessment of Geographic Pharmacy Accessibility in Qom (Iran)- a Geographic Information System Analysis

    Nov 1, 2012, 00:00

  • PHS89 How Can We Measure the Impact of Clinical Pharmacy Interventions? A Retrospective Drug Cost Analysis

    Nov 1, 2012, 00:00

  • PMD16 The Budgetary Impact of Using the Simtomax® Testing Kit for the Diagnosis of Coeliac Disease in the UK

    Nov 1, 2012, 00:00

  • PHP54 Chemical Drug Price Index Study

    Nov 1, 2012, 00:00

  • PRS1 The Use of Montelukast and Neuropsychiatric Disturbances Among Pediatric Asthmatics- A Nested Case-Control Study

    Nov 1, 2012, 00:00

  • PDB7 Network Meta-Analysis of Fixed Dose Combination Therapies for the First-Line Treatment of Type 2 Diabetes Mellitus

    Nov 1, 2012, 00:00

  • PCN115 Quality of Life in Lung Cancer Patients During Adjuvant or Palliative Chemotherapy

    Nov 1, 2012, 00:00

  • PND34 Long-Term Effects on Costs and Quality Adjusted Life Years of Patients With Relapsing-Remitting Multiple Sclerosis Treated With Laquinimod- Results Based on the Allegro and Bravo Trials

    Nov 1, 2012, 00:00

  • PCV55 A Cost-Effectiveness Analysis of Coralan® (Ivabradine) Plus Standard Care Versus Standard Care Alone in Chronic Heart Failure

    Nov 1, 2012, 00:00

  • PRM141 Combining an Ordered Logit Model With Individual Patient-Level Data to Robustly Estimate Within-Category Visual Acuity Starting Distributions- An Innovative Modeling Approach in the Case of Vitreomacular Traction

    Nov 1, 2012, 00:00

  • PMS15 Determinants of Total Health Care Costs Associated With Ankylosing Spondylitis Prevalent Cases in Turkey

    Nov 1, 2012, 00:00

  • PMS1 Irrational Use of Steroids- A Warning for the Health Care System

    Nov 1, 2012, 00:00

  • PHP101 The Implementation of Diagnostic Related Groups (DRGs) in Gree One Move Forward to Efficiency

    Nov 1, 2012, 00:00

  • PRM4 QALY and Productivity Loss- Empirical Evidence for “Double Counting”

    Nov 1, 2012, 00:00

  • PCV64 Cost-Effectiveness of Ticagrelor in the Management of Acute Coronary Syndromes in Belgium

    Nov 1, 2012, 00:00

  • PIN4 The Impact of Pharmacist-Led Antimicrobial Stewardship in Intensive Care Units in a Regional Hospital in Taiwan

    Nov 1, 2012, 00:00

  • PHS12 Meta-Analysis of Parkinson's Disease Risk With Hypertension, Serum Total Cholesterol, and Diabetes Mellitus

    Nov 1, 2012, 00:00

  • PRM48 The Half-Cycle “Correction”- How Much of a Correction is it?

    Nov 1, 2012, 00:00

  • PMS6 Anti-Tumour Necrosis Factor (TNF) Drugs for the Treatment of Psoriatic Arthritis (PsA)

    Nov 1, 2012, 00:00

  • PHP110 Real-World Diagnosis and Treatment Patterns of Iron Deficiency Anemia in China

    Nov 1, 2012, 00:00

  • PDB11 Efficacy of Exentaide in Type 2 Diabetes Mellitus in a Local Hospital in Taiwan- a Pilot Study

    Nov 1, 2012, 00:00

  • PMH4 Mirror Image Studies of Risperidone Long-Acting Injection for Chronic Schizophrenia and Schizoaffective Disorder

    Nov 1, 2012, 00:00

  • PHP1 Incorporating the Patient's Voice Into the Assessment of Medical Devices- A Comparison of the United States and Europe

    Nov 1, 2012, 00:00

  • PMD66 Health-Economic Analysis of the Systematic Use of Single-Hand Secured Huber Needles (Positive-Pressure) in French Hospitals

    Nov 1, 2012, 00:00

  • PHP65 Quality of Care- Reference and Counter Reference from Family Physicians and Rheumatologists' Perspectives– A Pilot Study

    Nov 1, 2012, 00:00

  • PRS13 Variation of Cost of Chronic Obstructive Lung Disease in Adults in Germany- A Systematic Review

    Nov 1, 2012, 00:00

  • PRM130 Translatability of Response Sets Used in Patient Reported Outcomes and Best Practices for Development

    Nov 1, 2012, 00:00

  • PIN16 Cost-Effectiveness of Rotavirus Immunization in Indonesia Taking Breastfeeding Patterns Into Account

    Nov 1, 2012, 00:00

  • PCN127 Policy Maker, Please Carefully Consider Your Needs- Does Outcomes Research of Bortezomib for Advanced Multiple Myeloma Reduce Uncertainty?

    Nov 1, 2012, 00:00

  • PCV31 Cost-Effectiveness of Apixaban Versus Enoxaparin for the Prevention of Postsurgical Venous Thromboembolism in Korea

    Nov 1, 2012, 00:00

  • PMD34 Economic Comparative Evaluation of a Surgical Film Dressing in the Management of Post-Operative Surgical Wounds. An Inexepensive and Simple Solution to a Costly Problem

    Nov 1, 2012, 00:00

  • PMD37 Forecasting the Prevalence and Economic Burden of Atrial Fibrillation in Selected Countries, 2010-2025

    Nov 1, 2012, 00:00

  • PRM21 Communicating to Decision Makers the Parameter Uncertainty in the IQWiG Efficiency Frontier Approach

    Nov 1, 2012, 00:00

  • PCV37 VIP Study- Incremental Cost During Hospitalization After Total Knee and Hip Arthroplasty in Brazilian Health Care Services

    Nov 1, 2012, 00:00

  • PRM38 Measurement Properties of the Spanish Version of the Pediatric Promis Fatigue Item Bank

    Nov 1, 2012, 00:00

  • PHS58 Change in Health-Related Quality of Life After Occpational Therapy in Community-Dwelling Dependent Elderly- A Randomised Controled Trial

    Nov 1, 2012, 00:00

  • PMH45 Health-Related Quality of Life Patient-Reported Outcomes in Schizophrenia

    Nov 1, 2012, 00:00

  • PMS61 Health-Related Quality of Life After Vertebral Fracture- Differences Between the EQ-5D and Time-Trade-Off Instruments

    Nov 1, 2012, 00:00

  • MO4 Treatment Discontinuation in Economic Modelling of Oncology Therapies- Systematic Review and Best Practices Analysis

    Nov 1, 2012, 00:00

  • PMS69 Key Drivers for Pricing and Reimbursement for Biologic Drugs in France

    Nov 1, 2012, 00:00

  • PCN19 Cost-Effectiveness Analysis of Temsirolimus in Patients With Poor Risk Renal-Cell Carcinoma

    Nov 1, 2012, 00:00

  • CA3 Use of Health Care Administrative Databases to Estimate the Burden of Breast Cancer

    Nov 1, 2012, 00:00

  • PMD45 Estimating Economic Impact of Angiogenesis-Specific Imaging in Metastatic Breast Cancer

    Nov 1, 2012, 00:00

  • ISPOR 5TH Asia-Pacific Conference Research Abstracts Author Index

    Nov 1, 2012, 00:00

  • PCN9 Modeling Lifetime Effectiveness of Denosumab Versus Placebo in Men With Castration Resistant Prostate Cancer (CRPC) at High Risk of Developing Bone Metastasis (BM)

    Nov 1, 2012, 00:00

  • PHP125 An Early Assessment of the German Federal Joint Commission Resolutions of Additional Clinical Benefit

    Nov 1, 2012, 00:00

  • PRM2 Development and Validation of a Health Economic Model for Corticosteroid-Induced Osteoporosis in Postmenopausal Women With Rheumatoid Arthritis in Japan

    Nov 1, 2012, 00:00

  • PIN47 Cost-Effectiveness Analysis of the Primovaccination of Newborns Against Tuberculosis in Slovakia

    Nov 1, 2012, 00:00

  • PRS46 Health Care Resource Use of Patients With Cystic Fibrosis (CF) in the UK

    Nov 1, 2012, 00:00

  • PCV58 The Cost Effectiveness of Amlodipine Valsartan and Hydrochlorothiazide Single Pill Combination in Turkey

    Nov 1, 2012, 00:00

  • PIN57 Economic Evaluation of 13-Valent Pneumococcal Vaccine in High Risk Pediatric Population, From the Public Payer Perspective in Brazil

    Nov 1, 2012, 00:00

  • PIN29 Length of Stay and Cost Due to Recurrent Clostridium Difficile Infections (CDI) at a University Hospital in Finland

    Nov 1, 2012, 00:00

  • PGI2 Infliximab Reduces the Risk of Surgical Interventions and Hospitalization in Patients With Inflammatory Bowel Disease

    Nov 1, 2012, 00:00

  • PDB21 Direct Medical Costs of Diabetes-Related Complications in India

    Nov 1, 2012, 00:00

  • PDB48 Health Care Resources Utilization and Costs Associated With the Management of Patients With Acromegaly- An Analysis Based on the Ramq Database

    Nov 1, 2012, 00:00

  • PIH44 Contraceptive Utilization in Women Who Had an Abortion- A Canadian Cohort-Study

    Nov 1, 2012, 00:00

  • PIN37 The Economic Burden of Initial Empiric Antibiotic Failure on Health Care Resource Utilization for Hospitalized Patients With Complicated Intra-Abdominal Infections (cIAIs) in Greece

    Nov 1, 2012, 00:00

  • PMD43 Comparison of Actual Costs Versus DRG Revenue of Cervical Arthroplasty in Patients With Degenerative Disc Disease in Germany

    Nov 1, 2012, 00:00

  • PSY19 Access to Care and Health Outcomes Among the Hemophilia A Population in Developing Countries- A Comparison Between Philippines and Colombia

    Nov 1, 2012, 00:00

  • PHP88 A Reimbursement Method for the Public Health Centers in Greece

    Nov 1, 2012, 00:00

  • PRS47 Analysis of New Prescriptions for Long-Acting β2-Agonists in Five European Countries in 2011

    Nov 1, 2012, 00:00

  • PSY15 Impact of Chronic Immune-Mediated Inflammatory Diseases on Work Productivity- Literature Review

    Nov 1, 2012, 00:00

  • PCN51 Comprehensive Investigation of Adverse Event (AE)-Related Costs in Patients With Metastatic Breast Cancer (mBC) Treated With First- and Second-Line Chemotherapies

    Nov 1, 2012, 00:00

  • PSY37 Patient-Reported Outcome (PRO) Assessments in Systemic Lupus Erythematosus (SLE)

    Nov 1, 2012, 00:00

  • PHP75 Is Orphan Designation a Driver of Orphan Drug Pricing?

    Nov 1, 2012, 00:00

  • PMD26 Cost Effectiveness of HIV Testing in Non-Traditional Settings – the Hints Study

    Nov 1, 2012, 00:00

  • PCN71 Cost-Effectiveness Analysis of Cetuximab and Panitumumab as First-Line Therapies for Metastatic Colorectal Cancer in Spain

    Nov 1, 2012, 00:00

  • DB4 Patient-Reported Hypoglycaemia in Real-World Settings in Seven European Countries

    Nov 1, 2012, 00:00

  • PHS14 Clinical and Economic Analysis of “MoliCare® Premium Extra Soft” Diapers Efficient Application for Dermatitis and Pressure Ulcers' Prophylaxis for Immobile Urinary-Incontinent Patients

    Nov 1, 2012, 00:00

  • PRM52 Minimum Run-Time Requirements to Reduce Monte Carlo Error in Stochastic Simulations

    Nov 1, 2012, 00:00

  • PRM82 Verification of Proportional Hazards Assumption in Cost-Effectiveness Analysis (CEA)

    Nov 1, 2012, 00:00

  • PCN3 Improvement of the 3rd Generation Colorectal Cancer Gene Chip

    Nov 1, 2012, 00:00

  • PHP161 Integration of Value of Information Into the Decision Making Process in Ireland

    Nov 1, 2012, 00:00

  • PGI37 Finalisation and Psychometric Validation of a new Questionnaire Measuring Patient Satisfaction With Anti-TNF Treatments in Severe Crohn's Disease

    Nov 1, 2012, 00:00

  • PIH35 Disability-Adjusted-Life-Years (DALYs) Loss in Postmenopausal Women with Osteoporosis

    Nov 1, 2012, 00:00

  • PCN86 Cost-Effectiveness Analysis of Abiraterone for the Treatment of Advanced Prostate Cancer Under the Brazilian Private Health Care System

    Nov 1, 2012, 00:00

  • PHP27 The Effect of Retirement on Mental Health

    Nov 1, 2012, 00:00

  • PHP82 Health Care Utilization Research in Germany- Characterization of the Nordbaden Database

    Nov 1, 2012, 00:00

  • PCN63 The Relative Value of Dasatinib Versus Imatinib as First-Line Treatment for Chronic Myeloid Leukemia

    Nov 1, 2012, 00:00

  • PND66 Therapeutic Equivalence as a Means of Improving the Efficiency in the Treatment of Multiple Sclerosis

    Nov 1, 2012, 00:00

  • PMS37 Economic Evaluation Model of Biologic Therapies for Moderate to Severe Psoriatic Arthritis in Germany

    Nov 1, 2012, 00:00

  • PSU19 Does the Novel Renal Marker NGAL (Neutrophil Gelatinase-Associated Lipocalin) Result in Cost Savings in Patients With Renal Impairment Following Cardiac Surgery?

    Nov 1, 2012, 00:00

  • PCN156 Value Based Pricing in the UK; Industry Stakeholders' Perspectives

    Nov 1, 2012, 00:00

  • PDB10 Effectiveness of Vildagliptin Compared to Sulfonylureas in Type 2 Diabetes Patients in Germany- Results From a Large Real-Life Cohort Study

    Nov 1, 2012, 00:00

  • PSY48 Developing a National Outcomes Treatment Registry for Hepatitis C Patients in the Era of the DAAs

    Nov 1, 2012, 00:00

  • PRM40 Efficacy of Liraglutide Compared to Exenatide and Insulin Glargine in Patients With Diabetes Type 2- A Meta-Analysis

    Nov 1, 2012, 00:00

  • PHS64 Shared Decision Making in Secondary Care- Rheumatologic Patient's Perspective

    Nov 1, 2012, 00:00

  • PHS62 Assessment of Patient Satisfaction With Chronic Treatment Using the European Patient Survey in Atrial Fibrillation (EUPS-AF)

    Nov 1, 2012, 00:00

  • QL1 EQ-5D-5L Valuation Project for the Spanish Population – A Descriptive Overview and Preliminary Results

    Nov 1, 2012, 00:00

  • PCN1 Use of the 5-HT3-RA Antiemetics in the Prevention and Treatment of Radiation Induced Nausea and Vomiting

    Nov 1, 2012, 00:00

  • PHS69 Impact Assessment of Minnesota Model for Alcohol Rehabilitation in Hospitalized Patients

    Nov 1, 2012, 00:00

  • PDB2 Epidemiology, Patient Burden and Related Costs of Obesity in India

    Nov 1, 2012, 00:00

  • PND22 Descriptive Analysis of the Direct Costs of Relapsing-Remitting Multiple Sclerosis in the Mexican Setting

    Nov 1, 2012, 00:00

  • PRM87 Cross-Cultural Validation of the Huntington Quality of Life Instrument in Spain

    Nov 1, 2012, 00:00

  • PIN17 Cost-Utility Analysis of Pneumococcal Nontypeable Haemophilus Influenza Protein-D Conjugate Vaccine (PHiD-CV) in Hong Kong Using Transmission Dynamic Model

    Nov 1, 2012, 00:00

  • PSS13 Cost-Effectiveness of Specialized Treatment Based on Cognitive Behavioural Therapy Versus Usual Care for Tinnitus

    Nov 1, 2012, 00:00

  • PGI35 Health-Related Quality of Life in Patients With Haemophilia and Inhibitors on Prophylaxis With Anti-Inhibitor Complex Concentrate- Results From the Pro-Feiba Study

    Nov 1, 2012, 00:00

  • UT3 Estimating Preference-Based Index from Cancer-Specific Quality of Life Measures for Use in Cost-Utility-Analysis

    Nov 1, 2012, 00:00

  • PGI38 The Consumption of Proton-Pump Inhibitors in Slovakia

    Nov 1, 2012, 00:00

  • PCN54 Economic Burden Associated With Pancreatic Cancer in Europe

    Nov 1, 2012, 00:00

  • PHS79 The Analysis of the Formulary Committees in Kazakhstani Regions

    Nov 1, 2012, 00:00

  • PSU7 Seasonal Periodicity of Secondary Hip Replacement After Femoral Neck Fractures With Reduction Internal Screw Fixation Aged Over 60

    Nov 1, 2012, 00:00

  • PND24 Methodological Considerations in Cost of Illness Studies on Alzheimer Disease

    Nov 1, 2012, 00:00

  • PHS54 Use of Health Care Administrative Databases to Estimate the Health Care Burden of Bone or Bone Marrow Metastatic Deases in Breast Cancer Patients- A Population-Based Study

    Nov 1, 2012, 00:00

  • PHS94 Involvement of CNS Specialists in Health Care Provision for Patients With Attention-Deficit/Hyperactivity Disorder (ADHD)- New Data from Nordbaden, Germany, 2003 - 2009

    Nov 1, 2012, 00:00

  • PRM49 EQ-5D Versus Disease-Specific HR-QoL Instruments – No Contest?

    Nov 1, 2012, 00:00

  • PHP20 Real-World Utilization Pattern of Biologics in Rheumatoid Arthritis- A Population-Based Study

    Nov 1, 2012, 00:00

  • PRM1 What is the Evidence on Using Selected Types of Sutures for Abdominal Surgery – Novel Approach to Create Dynamic Tool for Colleting and Reviewing Available Data

    Nov 1, 2012, 00:00

  • PHS29 Cost of Treating Patients With Obstructive Sleep Apnea/Hypopnea Sydrome in the Sotiria Chest Hospital in Greece

    Nov 1, 2012, 00:00

  • DB1 Epidemiology, Treatment and Economic Burden of Type 2 Diabetes Mellitus With Nephropathy Complications in China

    Nov 1, 2012, 00:00

  • PRM129 Final Reports for Translation and Linguistic Validation of Clinical Outcome Assessments

    Nov 1, 2012, 00:00

  • PSY17 Estimating the Direct Costs of Patients Treated With Eltrombopag in the French Setting

    Nov 1, 2012, 00:00

  • PSS29 Assessing the Clinical Meaningfulness of 1-Line Average Change in Visual Acuity Among Patients With Diabetic Macular Edema- Evidence From Health-Related Quality of Life Changes

    Nov 1, 2012, 00:00

  • PDB14 Prevalence of Hypertension and/or Obesity in Patients With Type 2 Diabetes Mellitus in Asia- A Systematic Literature Review

    Nov 1, 2012, 00:00

  • PIN42 Cost-Effectiveness-Analysis of the Combination- Therapy Telaprevir, Peg-IFNα2a and Ribavirin in Patients With Chronic Hepatitis-C in Austria

    Nov 1, 2012, 00:00

  • PMD35 Cost Analysis of an Implantable Loop Recorder, Reveal© XT, for the Diagnosis of Atrial Fibrillation in Patients Who Underwent Cryptogenic Stroke From the Perspective of a Tertiary Spanish Hospital

    Nov 1, 2012, 00:00

  • PRM78 Mapping of the National Eye Institute 25-Item Visual Functioning Questionnaire (VFQ-25) to EQ-5D Utility Scores

    Nov 1, 2012, 00:00

  • PMD29 Comparing the Economic Impact of Prosthesis Choice in Unicompartmental Knee Arthroplasty Procedures- Development of an Economic Model

    Nov 1, 2012, 00:00

  • PMH18 Treatment Patterns and Costs in Patients With Schizophrenia in Germany

    Nov 1, 2012, 00:00

  • PCV44 Economic Evaluation of a Single-Pill Triple Combination With Valsartan, Amlodipine and Hydrochlorothiazide Against Its Dual Components in Greece. The Generic Substitution Case

    Nov 1, 2012, 00:00

  • PSS5 New Formulation of Travoprost Reduces Dry Eye Occurrence and Costs in Glaucoma Patients- Model-Based Results for Hong Kong

    Nov 1, 2012, 00:00

  • PSS8 Health Burden of Vision Problems in Asia- A Study of Malays and Indians in Singapore

    Nov 1, 2012, 00:00

  • PCN21 Melody Brasil- Real World Health Outcomes of the Treatment of Metastatic Melanoma Patients in the Brazilian Health System

    Nov 1, 2012, 00:00

  • PHS42 Cost-Effectiveness of Infant Vaccination With 10 and 13-Valent Pneumococcal Conjugate Vaccines in the Russian Federation

    Nov 1, 2012, 00:00

  • PMS4 Inhibition of Carrageenan-Induced Edema by Stachys Fruticulosa Extract in Rats

    Nov 1, 2012, 00:00

  • PMS63 Assessment of the Osteoporosis Self-Efficacy Scale in Relation to Osteoprotective Behaviors among Type 2 Diabetics Patients in North Malaysia

    Nov 1, 2012, 00:00

  • PCV118 Fixed-Dose Combinations and Their Value to Payers

    Nov 1, 2012, 00:00

  • PMD19 Budget Impact Analysis of Balloon Sinuplasty Versus Classic Functional Endoscopic Sinus Surgery. Using a Budget Impact Model to Identify Country Specific Market Access Strategy

    Nov 1, 2012, 00:00

  • PRM15 Assessing the Broader Impact of Vaccinations- A Government Perspective Quantitative Analytic Framework Applied to Vaccination

    Nov 1, 2012, 00:00

  • PCN159 Melody Brazil - Treatment Patterns in Brazilian Health Care System

    Nov 1, 2012, 00:00

  • PIN32 Economic Evaluation of Boceprevir for the Treatment of Patients With Genotype 1 Chronic Hepatitis C Virus Infection in Hungary

    Nov 1, 2012, 00:00

  • PSY30 Cost-Effectiveness of Ustekinumab in the Management of Moderate-to-Severe Plaque Psoriasis in Mexico

    Nov 1, 2012, 00:00

  • PHP138 Impact of Value Based Pricing on Future of Patient Access Schemes in the UK

    Nov 1, 2012, 00:00

  • PHP103 Challenges and Future Prospects of Nursing Workforce in Greece

    Nov 1, 2012, 00:00

  • PRS3 Real World Effectiveness and Relative Effectiveness of Omalizumab. An Historic-Prospective Design Study

    Nov 1, 2012, 00:00

  • PHP35 Is There a Difference in Prescription Medication Utilization Between Aged Adults with and Without Disability in the United States?

    Nov 1, 2012, 00:00

  • PCV67 Mind the Gap! Geographic Transferability of Economic Evaluation in Health

    Nov 1, 2012, 00:00

  • PIH24 Economic Evaluation of Ulipristal Acetate Tablets for the Treatment of Patients with Moderate and Severe Symptoms of Uterine Fibroids

    Nov 1, 2012, 00:00

  • PCV112 Dosage Analysis of CHF Therapies on the Basis of Hungarian Claim Database

    Nov 1, 2012, 00:00

  • PSY42 Effectiveness and Safety of Anti-TNF Agents in Treatment of Moderate to Severe Psoriasis Vulgaris- Results of Work Productivity and Daily Activity Impairment

    Nov 1, 2012, 00:00

  • PRM108 Reliability, Validity, and Ability to Detect Change of the Fact-an for Use in Patients With Anaemia Associated With Chronic Kidney Disease

    Nov 1, 2012, 00:00

  • PMD81 Evaluation of Product Wastage From Modern Human Growth Hormone Administration Devices

    Nov 1, 2012, 00:00

  • PGI40 Physician-Initiated Treatment Patterns of Ulcerative Colitis (UC) Patients in the UK- a Review of Chart-Abstracted Data

    Nov 1, 2012, 00:00

  • PHS81 Health Care Organizations/Services Clustering- Comparison of Several Techniques Using UK Data

    Nov 1, 2012, 00:00

  • PHP58 Direct Cost of Adverse Drug Reaction Treatment in Hospitalized Patients in Nakhon Pathom Hospital, Thailand

    Nov 1, 2012, 00:00

  • PDB49 Cost and Health Care Resources Utilization in the Management of Cushing'S Disease- An Analysis Based on the Ramq Database

    Nov 1, 2012, 00:00

  • PHP37 New Classification of Traditional and Innovative Pharmaceutical Payment Methods

    Nov 1, 2012, 00:00

  • PRM140 An Applied Comparison of Meta-Analysis Techniques Using Bacille Calmette Guerin Vaccine Studies

    Nov 1, 2012, 00:00

  • PMD12 A Budget Impact Model to Investigate Potential Cost Savings Associated With the Use of Safety-Engineered Sharp Devices in Belgium

    Nov 1, 2012, 00:00

  • PRM94 A New Step in the Use of Computer Adaptive Tests for Measuring Quality of Life. Cultural Adaptation and Calibration in Spain of Two Promis Item Banks- Pain-Behaviour and Pain-Interference

    Nov 1, 2012, 00:00

  • PHP30 Using Nationwide Administrative Data to Evaluate Generic Drug Pricing and Physician Prescription

    Nov 1, 2012, 00:00

  • PCN138 Patterns of Anticoagulant Use in Cancer Patients Receiving Chemotherapy

    Nov 1, 2012, 00:00

  • PHP155 A Comparative Study of the Multiple Technology Assessment Process in the UK and Australia

    Nov 1, 2012, 00:00

  • PMD67 The Cost Effectiveness of Platelet Rich Plasma Versus Corticosteroids in the Treatment of Lateral Epicondylitis

    Nov 1, 2012, 00:00

  • PMD32 Outcomes and Costs of Isolated Aortic Valve Replacements Associated With the Mini-Invasive Implantation of a New Sutureless and Collapsed Valve in Italy, France, Germany, and UK

    Nov 1, 2012, 00:00

  • PCV30 Cost-Effectiveness of Cilostazol, Naftidrofuryl Oxalate, Pentoxifylline and Inositol Nicotinate for the Treatment of Intermittent Claudication in People with Peripheral Arterial Disease in the Uk

    Nov 1, 2012, 00:00

  • PHS90 How Do Pharmacists Advise Diabetes Patient Self-Management During the Holy Month of Ramadan?

    Nov 1, 2012, 00:00

  • PHP64 Analyzing the Annual Adverse Drug Reactions at a Regional Teaching Hospital of Southern Taiwan

    Nov 1, 2012, 00:00

  • PRM4 Assessment of Immunosuppressive Therapies for Renal Transplantation - Criteria Considered for Evaluation by the EMA, European HTA Agencies and the German IQWiG

    Nov 1, 2012, 00:00

  • PND3 Relapses Requiring Intravenous Steroids and Multiple Sclerosis-Related Hospitalizations- Findings From the Phase 3 Define and Confirm Studies

    Nov 1, 2012, 00:00

  • PRM13 Methods for Estimating Survival Benefits in the Presence of Treatment Crossover- A Simulation Study

    Nov 1, 2012, 00:00

  • PIN68 Cost-Minimization Analysis of Caspofungin Versus Liposomal Amphotericin B for the Treatment of Febrile, Neutropenic Patients With a Presumed Fungal Infection in the Netherlands

    Nov 1, 2012, 00:00

  • PSY33 Item Reduction and Assessment of Measurement Properties of the Hunter Syndrome – Functional Outcomes for Clinical Understanding Scale (HS-FOCUS)

    Nov 1, 2012, 00:00

  • PMS4 Comparing the Efficacy and Safety of Biologics for the Treatment of Rheumatoid Arthritis Patients- A Network Meta-Analysis

    Nov 1, 2012, 00:00

  • PHP192 Recent Global Insights Into Risk Sharing Agreements- A Comparative Analysis

    Nov 1, 2012, 00:00

  • PSU30 Effects of Different Clinical Practices of Laparoscopic Surgery for Endometriosis Treatment on Cost of Therapy

    Nov 1, 2012, 00:00

  • Instructions for Authors

    Nov 1, 2012, 00:00

  • PSY2 Preliminary Validation of Collect Scale- A Co-Morbidity Assessment Tool for Patients With Chronic Lymphocytic Leukaemia

    Nov 1, 2012, 00:00

  • PSU26 Health-Related Quality of Life in Familial Amyloidotic Polyneuropathy Before and After Liver Transplantation- A Systematic Literature Review

    Nov 1, 2012, 00:00

  • PMH46 Determinants of Health-Related Quality of Life in Japanese Patients With Chronic Schizophrenia

    Nov 1, 2012, 00:00

  • PHP139 Which Criteria are Considered in Health Care Decisions? Insights from an International Survey of Policy and Clinical Decision Makers

    Nov 1, 2012, 00:00

  • PMS26 Assessment of the Burden of Rheumatoid Arthritis in Fran Analysis of a National Representative Claim Database

    Nov 1, 2012, 00:00

  • PRM23 Cost-Effectiveness Versus Patient Acceptability- The Exemplar of CFS/ME

    Nov 1, 2012, 00:00

  • PHP4 Financial Penalties for Improving Drug Adherence

    Nov 1, 2012, 00:00

  • PDB2 Systematic Literature Review of the Efficacy and Safety of Metformin Extended Release Relative to Metformin Immediate Release in the Treatment of Type 2 Diabetes Mellitus

    Nov 1, 2012, 00:00

  • PCN28 A Feasibility Study on Applying Preference-Based Quality-of-Life Measures in Chronic Myeloid Leukemia Outpatients Treated With Imatinab in Taiwan

    Nov 1, 2012, 00:00

  • PCV30 Assessment of the Hospital Costs of Mitral Regurgitation (MR) Patients, a French National Hospital Database Analysis

    Nov 1, 2012, 00:00

  • PMH37 Systematic Review of Health State Utilities in Attention Deficit Hyperactivity Disorder (ADHD)

    Nov 1, 2012, 00:00

  • PIH36 Quality of Life of Medical University of Warsaw Faculty of Pharmacy Students in 2010-2012

    Nov 1, 2012, 00:00

  • PCN149 Uncertainty Regarding NICE's End-of-Life Small Patient Population Criteria

    Nov 1, 2012, 00:00

  • DU4 Inappropriate Use of Drugs Influences Health Budget of Population

    Nov 1, 2012, 00:00

  • PIN27 Cost Analysis of Voriconazole Versus Liposomal Amphotericin B for Primary Therapy of Invasive Aspergillosis Among Hematologic Patients in Germany

    Nov 1, 2012, 00:00

  • PSU3 Prolonged Effectiveness of Coronary Artery Bypass Surgery Versus Drug-Eluting Stents in Diabetics With Multi-Vessel Disease- An Updated Meta-Analysis

    Nov 1, 2012, 00:00

  • PRM139 Including Patients in Multiple Groups and Multiple Times in the Same Group in Longitudinal Observational Research- A Cystic Fibrosis Example

    Nov 1, 2012, 00:00

  • PRS39 Preference and Willingness to Pay for a Treatment of Pulmonary Arterial Hypertension

    Nov 1, 2012, 00:00

  • PHS36 Cost Drivers of Household Treatment of Presumptive Malaria in Home-Based Management of Malaria in Ejisu-Juaben Municipality

    Nov 1, 2012, 00:00

  • PHP152 The Early Benefit Assessment of Drugs That are Launched Before 2011

    Nov 1, 2012, 00:00

  • PUK18 Cost-Effectiveness of Angiotensin-Converting Enzyme Inhibitors in Non-Diabetic Advanced Renal Disease – A Dutch Perspective

    Nov 1, 2012, 00:00

  • PHS5 Assessing the Clinical and Economic Burden of United States Veteran Ankylosing Spondylitis Patients

    Nov 1, 2012, 00:00

  • PHP17 Consumption Patterns, Traditional Market and Regulation in the Pharmaceutical Industry. Evidence for Two Therapeutic Groups in Insured Population

    Nov 1, 2012, 00:00

  • PDB51 Resource Utilization in the Management of Acromegaly- An Analysis From Southwest Ontario

    Nov 1, 2012, 00:00

  • PRM43 A Systematic Review on the Application of Cardiovascular Risk Prediction Models in Pharmacoeconomics, With a Focus on Primary Prevention

    Nov 1, 2012, 00:00

  • PMS19 Investigation of Comparative Clinical Outcomes Profiles and Cost Effectiveness of Four Classes of Anti Arthritic Drugs Using HAQ DI, DAS -28 and EQ5D3L in a Tertiary Care Hospital in Western India

    Nov 1, 2012, 00:00

  • PHP180 Multiple Correspondence Analysis to Understand the Role of Multiprofessional Team for Shared Decision Making to Implementation in Clinical Practice

    Nov 1, 2012, 00:00

  • PIH12 Burden of Early-Onset Neonatal Sepsis in the Russian Federation

    Nov 1, 2012, 00:00

  • PHS67 Rasch Model Validation of a Peer Relations Scale for People Treated for Psychoactive Substance Use Disorder

    Nov 1, 2012, 00:00

  • PCV94 The Influence of Disease-Specific Symptoms on the Health-Related Quality of Life in Patients With Atrial Fibrillation

    Nov 1, 2012, 00:00

  • PRM173 On the Probability of Intertemporal Indifference

    Nov 1, 2012, 00:00

  • RE2 A Detailed Comparison of Dutch and Swedish Drug Reimbursement Decisions- What Evidence is Available, Which Criteria are Used, and is the Decision-Making Process Transparent?

    Nov 1, 2012, 00:00

  • PHP81 Microeconomic Surplus or Convenience in Health Care- Applied Economic Theory in Health Care in Three European Countries

    Nov 1, 2012, 00:00

  • PMD65 The Cost Effectiveness of Hand Held Ultrasound Scanning for AAA in Elderly Subjects With a History of Smoking

    Nov 1, 2012, 00:00

  • PDB3 Epidemiology, Patient Burden and Related Costs of Obesity in China

    Nov 1, 2012, 00:00

  • PGI15 Cost-Effectiveness Analysis of Lactest, a New Diagnostic Drug Test for Hypolactasia in Spain

    Nov 1, 2012, 00:00

  • PHP174 Physical Activity Matters- The Associations Between Body Mass Index, Physical Activity and Health-Realted Quality-of-Life Trajectories Over 10 Years

    Nov 1, 2012, 00:00

  • PCV93 Study of the Use of Quality of Life Questionnaires in Cardiac Diseases in Poland

    Nov 1, 2012, 00:00

  • PCV25 A Pharmacoeconomic Assessment of Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke in a Tertiary Hospital in China

    Nov 1, 2012, 00:00

  • PRS5 Dual Bronchodilation With Indacaterol and Tiotropium in Combination Versus Triple Therapy, Fixed-Dose Combinations, and Monotherapy in COPD – a Network Meta-Analysis of FEV1

    Nov 1, 2012, 00:00

  • PMS71 Utilization of Duloxetine and Celecoxib in Osteoarthritis Patients

    Nov 1, 2012, 00:00

  • PRS7 The Effect of Chronic Obstructive Pulmonary Disease (COPD) on Health Status in Urban China

    Nov 1, 2012, 00:00

  • PRM143 Cluster Analysis and Principal Component Analysis to Assess the Variability of Data in Cost Evaluations- Methods and Applications in Oncology

    Nov 1, 2012, 00:00

  • PIH16 Epidemiology of Herpes Zoster and Its Related Resource Utilization- A Large Population-Based Study in Israel

    Nov 1, 2012, 00:00

  • DB1 Assessing the Relationship Between the Effect of Glycemic Control and Avoided Symptomatic Hypoglycemia on Quality of Life in the Management of Type 2 Diabetes

    Nov 1, 2012, 00:00

  • PCV23 Beta Blockers for Treatment of Chronic Heart Failure in Spain- Review of the Economic Evidence and Efficiency Analysis

    Nov 1, 2012, 00:00

  • PSS26 Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA)- An Integrated Approach of Outcomes Measurement in Nail Psoriasis

    Nov 1, 2012, 00:00

  • PCN20 Inhaled Corticosteroid Use and Risks of Lung Cancer and Laryngeal Cancer

    Nov 1, 2012, 00:00

  • PHP88 Workplace-Based Smoking Cessation Programmes – Identifying the Gaps Between Evidence and Practice

    Nov 1, 2012, 00:00

  • PHP162 Review of NICE's Technology Appraisal Recommendations

    Nov 1, 2012, 00:00

  • PRM41 Designing Patient Registries- A Case-Study Using an Online Interactive Data Analysis Tool

    Nov 1, 2012, 00:00

  • PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases

    Nov 1, 2012, 00:00

  • PSY8 Number Needed to Treat (NNT) and Cost Estimation to Achieve a Major Molecular Response (MMR) in Newly Diagnosed Chronic Myeloid Leukemia Patients in Greece

    Nov 1, 2012, 00:00

  • PCN3 Quality-Adjusted Survival in Patients With Wild-Type (WT) KRASs Metastatic Colorectal Cancer (mCRC) Receiving First-Line Therapy With Panitumumab Plus FOLFOX Versus FOLFOX Alone

    Nov 1, 2012, 00:00

  • PMD56 Cost-Efectiveness Analysis Comparing the Application or Not of Whole Brain Irradiation Before Stereotectic Radiosurgery for the Treatment of One to Four Brain Metastases, According to Brazilians Third-Party Private Payer's Perspective ...

    Nov 1, 2012, 00:00

  • PHP26 Registries of Medical Devices in the European Union

    Nov 1, 2012, 00:00

  • PCN155 Is Sale of Tobacco and Smoking Prevalence Predictors of Future Lung Cancer Incidence?

    Nov 1, 2012, 00:00

  • PDB32 Diabetic Foot Syndrome Hospitalization Costs in Poland

    Nov 1, 2012, 00:00

  • PRM165 Validating Health Economic Models- Developing a Methodological Approach

    Nov 1, 2012, 00:00

  • PMS65 Detecting Potential Fibromyalgia Patients in Primary Care Settings- Validation of the Fibrodetect Screening Tool

    Nov 1, 2012, 00:00

  • DB3 Indirect Treatment Comparison (ITC) or Cost-Effectiveness Analysis (CEA)- a Study

    Nov 1, 2012, 00:00

  • PCN112 Characteristics of Cancer Patients Who Seek Cytostatic Therapy in Korea- A Pilot Study

    Nov 1, 2012, 00:00

  • ISPOR 15th Annual European Congress Disclosure Information for Research Presentations

    Nov 1, 2012, 00:00

  • PSY29 Title- The Challenge of Conducting a Prospective Economic Evaluation of a Pharmacogenetic Test

    Nov 1, 2012, 00:00

  • PRM64 Bayesian MTC Models to Combine Evidence From Different Trial Designs

    Nov 1, 2012, 00:00

  • PMD71 The Switch Study- The Impact of Continuous Glucose Monitoring on Health Care Resource Utilization

    Nov 1, 2012, 00:00

  • CA1 Discordant Diagnoses in Sarcoma, GIST and Desmoide Tumour in Fran Results From the Network RREPS

    Nov 1, 2012, 00:00

  • PND63 Effects of BG-12 on Quality of Life in Relapsing–Remitting Multiple Sclerosis- Findings From the Phase 3 Define Study

    Nov 1, 2012, 00:00

  • PHS85 The Cost of Public Cancer Prevention in Alberta

    Nov 1, 2012, 00:00

  • PIH2 Topical Estrogen Therapy in Postmenopausal Women - Indian Experience

    Nov 1, 2012, 00:00

  • PMS33 Cost-Efficacy Analysis of Biologic Drugs in Combination With DMARDs in Patients With Active Rheumatoid Arthritis and Inadequate Response to Traditional DMARDs in Portugal – A Simplified Approach

    Nov 1, 2012, 00:00

  • PDB29 Cost-Effectiveness Modelling of Type-1 Diabetes

    Nov 1, 2012, 00:00

  • PUK14 Cost-Effectiveness Analysis of Mirabegron Versus Tolterodine Extended Release in the Treatment of Patients With Overactive Bladder in the United States

    Nov 1, 2012, 00:00

  • PSS20 Cost-Utility Analysis of Treatments for Macular Edema Secondary to Retinal Vein Occlusion

    Nov 1, 2012, 00:00

  • PRM175 Identification and Translation of Culturally Bound Terms in Patient Reported Outcome Measures

    Nov 1, 2012, 00:00

  • PDB5 Real-World Treatment Patterns and Outcomes When Initiating Once-Daily Injectable Pen Therapy with Insulin Glargine or Liraglutide – an Electronic Medical Records Study

    Nov 1, 2012, 00:00

  • PMD58 Cost-Effectiveness Analysis of Leprosy Case Detection Methods in Northern Nigeria

    Nov 1, 2012, 00:00

  • PND73 Multiple Sclerosis in Germany- Outpatient Health Care Patterns

    Nov 1, 2012, 00:00

  • PMS5 Benefit-Risk Analysis of Adalimumab and Alternative Treatments for Moderate-to-Severe Rheumatoid Arthritis

    Nov 1, 2012, 00:00

  • PHS34 The Cost of Management of Common Cardiovascular Diseases is Higher on Weekends As Compared to Weekdays

    Nov 1, 2012, 00:00

  • PRM170 Optimizing Public Health Decision Over Time- A Dynamic Budget Optimization Model With Multiple Criteria Decision Making

    Nov 1, 2012, 00:00

  • PHS98 Clinical Characteristics, Treatment Patterns, and Resource Utilization in a Real-World European Population With Diverticulitis

    Nov 1, 2012, 00:00

  • PSY18 Clinical Outcomes, Resource Utilization and Treatment Cost of Myelodysplastic Syndromes and Acute Myeloide Leukemia in a Real World Setting- Single-Center Experience

    Nov 1, 2012, 00:00

  • PR4 The Effect of Neuropathic Pain on Health Status, Work Productivity Loss, and Health Care Resource Use in Japan

    Nov 1, 2012, 00:00

  • PHP41 Risk Management in Iranian Pharmaceutical Companies to Ensure Accessibility and Quality of Medicines

    Nov 1, 2012, 00:00

  • PIN45 Health Economic Impact of Infant Vaccination Program With PHiD-CV and PCV13 Using New Efficacy/Effectiveness Data. Example of Finland

    Nov 1, 2012, 00:00

  • PIN59 Cost-Effectiveness of Amoxicillin Clavulanate Directed Towards the Application of Indicated at Primary Care in the Treatment of Community Acquired Pneumonia, Acute Rhinosinusitis, Tonsillopharyngitis, and Acute Otitis Media

    Nov 1, 2012, 00:00

  • PIH45 Comparison of Unintended Pregnancy Rates in Users of 84/7, 21/7, and 24/4 Oral Contraceptive Regimens

    Nov 1, 2012, 00:00

  • PSU31 The Association Between Degenerative Disk Disease and Outcomes Among Patients Undergoing Lumbar Fusion Surgery

    Nov 1, 2012, 00:00

  • PCN2 Data Analyses on Prevalence and Treatment of Acute Myeloid Leukaemia in Germany

    Nov 1, 2012, 00:00

  • PCN31 Treatments Pattern and Outcomes of Ovarian Cancer Patients in a Patient-Centered Retrospective Research Registry

    Nov 1, 2012, 00:00

  • PRM86 Utilizing Indirect Treatment Comparisons in Metastatic Castration Resistant Prostate Cancer (mCRPC)

    Nov 1, 2012, 00:00

  • PHS61 Patient Involvement in Treatment Decisions and Its Perceived Impact on Patient Outcomes in Systemic Lupus Erythematosus (SLE)- A Comparison of Physician and Patient Perspectives

    Nov 1, 2012, 00:00

  • PHP39 Explaning Differences in EU5 Market Penetration Levels and Rates of Biosimilars- The Case of Epoetine, Granulocyte-Colony Stimulating Factor, and Growth Hormones

    Nov 1, 2012, 00:00

  • PIH28 The Project Sincope in Triveneto (PROSIT) Study. A Multicenter Study Regarding Syncope Management in an Italian Region

    Nov 1, 2012, 00:00

  • PCN18 Economic Evaluation of CT Colonography (CTC) Introduction Into the Colorectal Cancer Screening Program in Japan

    Nov 1, 2012, 00:00

  • PGI25 Cost-Utility Analysis of Telaprevir in Combination With Peginterferon Alpha and Ribavirin in Previously Treated Patients With Chronic Hepatitis C

    Nov 1, 2012, 00:00
  • «
  • 121 (current)
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • »